Angus Willoughby

The daughter of a Villawood director accused of a fraudulent design to divert valuable management fees for a development in Victoria has invoked her privilege against self-incrimination over the developer’s concerns that she may have destroyed evidence. 

German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix. 

The board administering the ESSSuper fund, which is facing a class action alleging it miscalculated the entitlements of transport shift workers in Victoria, has denied any liability, saying it was not involved in determining how entitlements were calculated.

An email to lawyers at Clifford Chance relied on to show investor Fiona Lock’s understanding of a contested $150 million profit sharing deal with trading platform Pepperstone did not open the door to further correspondence.

Former directors of New Century have won a dispute over a due diligence report prepared by Gilbert + Tobin in their litigation centred on royalty payments from a zinc mine in north-west Queensland.